These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 14624275)
1. The use of calcium antagonists in the therapy of hypertension in the elderly. Israili ZH Am J Ther; 2003; 10(6):383-95. PubMed ID: 14624275 [TBL] [Abstract][Full Text] [Related]
2. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
4. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials. Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234 [TBL] [Abstract][Full Text] [Related]
5. Current treatment of patients with hypertension: therapeutic implications of INSIGHT. Taddei S; Ghiadoni L; Salvetti A Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362 [TBL] [Abstract][Full Text] [Related]
6. Dihydropyridine calcium channel antagonists in the management of hypertension. Epstein BJ; Vogel K; Palmer BF Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473 [TBL] [Abstract][Full Text] [Related]
8. Cochrane in context: pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
10. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs. Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022 [TBL] [Abstract][Full Text] [Related]
11. Should calcium antagonists be first line drugs in hypertension? Furberg CD; Psaty BM Herz; 1995 Dec; 20(6):365-9. PubMed ID: 8582696 [TBL] [Abstract][Full Text] [Related]
17. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
18. Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective. Verdecchia P; Gentile G; Angeli F; Reboldi G Pol Arch Med Wewn; 2008 Sep; 118(9):513-6. PubMed ID: 18846987 [TBL] [Abstract][Full Text] [Related]
19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
20. Use of calcium channel blockers in hypertension. Conlin PR; Williams GH Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]